ozempic versus tirzepatide for Weight Loss | How It Works Mounjaro vs. Ozempic: What's the

Concerns with Unapproved GLP-1 Drugs Used for Weight Loss and Diabetes The FDA has documented over 600 adverse event reports related to compounded semaglutide by mid-2025, highlighting important safety concerns with non-approved alternatives

Medical Disclaimer This article is provided for educational and informational purposes only and is not intended as medical advice

In the later period, new users in both SGLT2i and GLP-1 RA cohorts were older, use of medications for type 2 diabetes was less intensive, and metabolic control was better, and although more patients had renal function assessed, patients had more severe CKD (stage 3: 44.052.1% vs

Despite strong growth and the opportunity ahead with orforglipron, Lilly's stock still trades at an attractive valuation